amgen

amgen

美 　英

• 网络安进；安进公司；美国安进公司

例句

but amgen has always been fiercely protective of its blockbuster , and a court battle would surprise no one.

但安进一向都极力保护它的明星药物，即使兴讼的话也不令人意外。

Amgen said the new labels on the drugs support its cause.

安进认为药物上新的标签将有助于实现申请目标。

Amgen said yesterday that it would formally ask the Centers for Medicare and Medicaid Services, or C. M. S. , to overturn that policy.

安进昨天表示，将正式请求政府医疗保险和公共医疗补助服务中心（CMS）彻底修改相关政策。

Amgen said it would present some new evidence, including information showing that more cancer patients are now needing blood transfusions.

安进表示将提供一些新的证据，包括如今需要输血的癌症患者正在增多等信息。

Amgen said it was pleased with the verdict and would seek an injunction to prevent Roche from releasing Mircera in the United States.

安进声称满意判决，并将寻求禁令以阻止罗氏在美国发布Mircera。

He cites in evidence a drug trial by Amgen, a biotech giant, where the researchers concluded that the drug was not effective.

Grove博士举出了这样的一个例子：那是一个由生物技术界的巨头——安进公司所进行的一项药品实验。在这项实验里，研究人员总结道，该药品并不有效。

The debate over whether the drugs are overused remains -- and riled some panelists who questioned Amgen's promotional tactics.

超剂量药物的争议尚未清楚，安进的营销策略激怒了质询的小组成员。

A federal judge has ruled that Mircera, a Roche anemia drug that would compete with Amgen's Epogen and Aranesp, violates an Amgen patent.

一次联邦审判认定Mircera，一个罗氏生产的用于同安进的Epogen和Aranesp竞争的药物，触犯了安进的专利权。

The court also granted a summary judgment in favor of Amgen on certain Roche defenses.

该法庭同时通过了一个安进乐于接受的对于罗氏特定反诉的简要判决。

S. dollars. The acquisition rumors and speculation, Pfizer and Amgen declined to comment.

对于收购的传言和猜测，辉瑞和安进拒绝评论。

After six months of intensive lab work, Amgen found it couldn't replicate the results and scrapped the project.

经过六个月深入细致的实验室研究后，Amgen发现无法重复试验结果，于是放弃了该项目。

Mr. Schoenebaum said Amgen's anemia business was still likely to decline sharply in the coming years because of the Medicare cutback.

Schoenebaum先生还认为由于Medicare（美国医疗保险）订单的减少，安进的贫血药物生意在未来几年仍有可能急剧下降。

Since FDA began scrutinizing the drugs last March, shares of Amgen have sunk 27 percent. U.

自从FDA去年三月开始审查这些药物，安进公司的股票已经降了27%。

The site (also available in plain old 2-D) looks pretty good even without the paper 3-D glasses that Amgen supplies upon request.

这个网站（也有普通2D版本）看起来很不错，即使没有Amgen所要求那样戴3D眼镜。

Companies such as Amgen, largely built on biological drugs, will face unprecedented price pressures.

主要依赖生物药的安进（Amgen）等公司，将面临前所未有的价格压力。

but the market positions of amgen , eli lilly and as - trazeneca are improving.

而安进、礼莱和阿斯立康公司的地位在提升。

Under agency rules, dialysis clinics receive a 6 percent profit on their use of Amgen's Epogen.

根据相关部门的规定，血液透析医疗中心在使用Amgen公司生产的Epogen时可以获得6%的利润。

Amgen's shares fell 17 cents yesterday to $56. 03, while Johnson & Johnson's rose 68 cents to $64. 59.

安进的股票昨天下跌17美分至每股56.03美元，而强生的股票涨68美分达每股64.59美元。

Since then, Amgen has sold more than $25 billion of Epogen, including $2. 5 billion last year.

从那个时候开始，安进销售了超过250亿美元的Epogen，包括去年的25亿。